JAYA JACOB: Open Payments
NPI 1194336149 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,991 in 89 payments from 18 companies in 2025. Trend: 2023 $935 · 2024 $1,542 · 2025 $1,991
Food & beverage: $1,991
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 17 | $387 |
| GlaxoSmithKline, LLC. | 12 | $273 |
| Actelion Pharmaceuticals US, Inc. | 10 | $254 |
| Baxter Healthcare | 13 | $228 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $173 |
| Regeneron Healthcare Solutions, Inc. | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Grifols USA, LLC | 3 | $73 |
| Insmed, Inc. | 3 | $70 |
| Merck Sharp & Dohme LLC | 3 | $61 |
Products named: NUCALA, Tyvaso, Hillrom - Vest System Model 105 Home Care, OPSUMIT, DUPIXENT, JASCAYD, TEZSPIRE, OFEV.
Industry payments across TX — which companies pay providers there.
